Effects of anti-neoplastic agents on the recovery of bacteria and yeasts in an automated blood culture system

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 1, 2000, Pages 63-67

  Kinnunen, Urpo ^a,b   Koistinen, Pirjo ^a   Syrjälä, Hannu ^a   Koskela, Markku ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b Lapponia Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; BACTERIAL GROWTH; BLOOD CULTURE; CANCER; CONTROLLED STUDY; FEVER; FUNGUS GROWTH; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; SEPSIS; YEAST;

EID: 0033969707     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540050164245     Document Type: Article

References (33)

1. Pizzo PA, Robichaud KJ, Wesley R, Commers JR. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 1982; 61: 153-65.
2. Bodey GP, Buekley M, Sathe YS, Freireich FJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-40.
3. Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975; 135: 715-9.
4. Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381-96.
5. Klastersky J. Empiric treatment of infections in neutropenic patients with cancer. Rev Infect Dis 1983; 5 Suppl 2: 21-31.
6. Schimpff SC, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenisillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061-5.
7. Gurwith MJ, Brunton JL, Lank BA, Ronald AR, Harding GKM. Granulocytopenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am J Med 1978; 64: 121-6.
8. Klastersky J, Zinner SH, Calandra T, Gava H, Glauser MP, Meunier F, et al. Empiric antimicrobial terapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Can Clin Oncol 1988; 24 Suppl 1; 35-45.
9. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 1994; 26: 77-84.
10. Kinnunen U, Syrjälä H, Koskela M, Kujala P, Koistinen P. Continuous-monitoring blood culture screening system improves the detection of bacteremia in neutropenic patients. Scand J Infect Dis 1996; 28: 287-92.
11. Hopfer RL, Moore DG, Fainstein V, Watkins S, Wenglar M. Routine use of BACTEC 16B bottles to remove antibacterial and antitumor agents from blood cultures of cancer patients. J Clin Microbiol 1983; 18: 759-64.
12. Peiris V, Oppenheim BA. Antimicrobial activity of eytotoxic drugs may inflence isolation of bacteria and fungi from blood cultures. J Clin Pathol 1993; 46: 1124-5.
13. Hughes WT, Pizzo PA, Wade JC, Armstrong D, Webb CD, Young LS. Evaluation of new anti-infective drugs for treatment of febrile episodes in neutropenic patients. Clin Infect Dis 1992; 15 Suppl 1: 206-15.
14. ® blood culture media. InterfaceTM, BTA006. Organon Teknika, 1994.
15. Bryant DH, Thorpe TC. Enhanced recovery with the aerobic FAN culture bottle for the BacT Alert microbial detection system. InterfaceTM, BTA I 005. Organon Teknika, 1994.
16. Baurain R, Deprez-De Campeneere D, Zenebergh A, Trouet A. Plasma levels of doxorubicin after iv bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man. Cancer Chemother Pharmacol 1982; 9: 93-6.
17. Benjamin RS, Riggs CE, Bachur NR. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res 1977; 37: 1416-20.
18. Greene RF, Collins JM, Jenkins JF, Speyer JL, Myers CE. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res 1983; 43: 3417-21.
19. Preisler HD, Gessner T, Azarnia N, Bolanowska W, Ebstem J, Early AP, et al. Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. Cancer Chemoter Pharmacol 1984; 12: 125-30.
20. Preiss R, Matthias M, Sohr R, Brockmann B, Huller H. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects. Int J Clin Pharmacol Ther Toxicol 1985; 23 Suppl 1: 79-88.
21. Hardy DJ, Hulbert BB, Migneault PC. Time to detection of positive BacT Alert blood cultures and lack of need for routine subculture of 5-to 7-day negative cultures. J Clin Microbiol 1992; 30: 2743-5.
22. Wilson ML, Mirret S, Reller LB, Weinstein MP, Reimer LG. Recovery of clinically important microorganisms from the BacT Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis 1993; 16: 31-4.
23. Ziegler R, Johnscher I, Martus P, Lenhardt D, Just HM. Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. J Clin Microbiol 1998; 36: 657-61.
24. Jacobs JY, Michel J, Sacks T. Bactericidal effect of combinations of antimicrobial drugs and antineoplastic antibiotics against Staphylococcus aureus. Antimicrob Agents Chemother 1979; 15: 580-6.
25. Bodet CA III, Jorgensen JH, Drutz DJ. Antibacterial activities of antineoplastic agents. Antimicrob Agents Chemother 1985; 28: 437-9.
26. Hamilton-Miller JMT. Antimicrobial activity of 21 anti-neoplastic agents. Br J Cancer 1984; 49: 367-9.
27. Kane TD, Alexander JW, Johannigman JA. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and or bacterial translocation in surgical patients. Ann Surgery 1998; 227: 1-9.
28. Gieringer JH, Wenz AF, Just H-M, Daschner FD. Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, opiperacillin, and netilmicin. Chemotherapy 1986; 32: 418-24.
29. Manten A, Terra JI. Some observations on antagonism between penicillin and antineoplastic antibiotics. Acta Physiol Pharmacol 1967; 15: 580-6.
30. Metcalfe D, Hughes WT. Effects of methotrexate on group A beta hemolytic streptococci and streptococcal infections. Cancer 1972; 30: 588-93.
31. Michel J, Jacobs JY, Sacks T. Bactericidal effects of combinations of antimicrobial drugs and antineoplastic antibiotics against gram-negative bacilli. Antimicrob Agents Chemother 1979; 16: 761-6.
32. Ueda Y, Saito A, Fukuoka Y, Yamashiro Y, Taki H, Yasuda T, Saikawa I. Interactions of β-lactam antibiotics and antineoplastic agents. Antimicrob Agents Chemother 1983; 23: 374-8.
33. Henriksson R, Holm S, Littbrand B. Interactions between antibiotics and antineoplaslic drugs on antibacterial activity in vitro. Acta Oncol 1990; 29: 43-6.